Avicanna (TSE:AVCN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Avicanna Inc., a biopharmaceutical company, has successfully completed a non-brokered private placement, raising $1.986 million through the sale of over 6.6 million units. These funds are earmarked for general working capital, administrative expenses, production, research, and debt repayment. The offering included common shares and warrants, with a hold period of four months in Canada.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.
